Gunasekaran Sivagami

Gunasekaran Sivagami

Auto-generated profile, based on publicly available information

Gunasekaran Sivagami

Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar 608 002, Tamilnadu, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2014 in Biomedicine & Preventive Nutrition
Verified
Journal Article
Closed access
SUS. Umayaparvathi
S. Umayaparvathi
SMS. Meenakshi
S. Meenakshi
VVV. Vimalraj
V. Vimalraj
AMARUMUGAM MUTHUVEL
ARUMUGAM MUTHUVEL
GSG. Sivagami
G. Sivagami
TBT. Balasubramanian
T. Balasubramanian

1 March 2012 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
GSGunasekaran Sivagami
Gunasekaran Sivagami
RVRajamanickam Vinothkumar
Rajamanickam Vinothkumar
CPChristo Paul Preethy
Christo Paul Preethy
ARAnvarbatcha Riyasdeen
Anvarbatcha Riyasdeen
MAMohammad Abdulkader Akbarsha
Mohammad Abdulkader Akbarsha
NNNamasivayam Nalini
Namasivayam Nalini

1 May 2013 in Experimental and Toxicologic Pathology
Verified
Journal Article
Closed access
Karthikkumar VenkatachalamKarthikkumar Venkatachalam
Karthikkumar Venkatachalam
SGSivagami Gunasekaran
Sivagami Gunasekaran
VJVictor Antony Santiago Jesudoss
Victor Antony Santiago Jesudoss
NNNalini Namasivayam
Nalini Namasivayam

1 April 2016 in Journal of Cancer Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
ASArivalagan Sivaranjani
Arivalagan Sivaranjani
GSGunasekaran Sivagami
Gunasekaran Sivagami
NNNamasivayam Nalini
Namasivayam Nalini
Purpose: Colorectal cancer (CRC) is a leading cause for cancer-related death and its prevention is of great importance throughout the world. Chemoprevention offers a novel approach to control the incidence of colon cancer. The present study was performed to evaluate the efficacy of carvacrol supplementation on colonic aberrant crypt foci (ACF), lipid peroxidation, and antioxidant defense system in 1,2-dimethylhydrazine (DMH)-induced colon carcinogenesis in male Wistar rats. Materials and Methods: The rats were randomly divided into six groups. Group 1, control rats received modified pellet diet; Group 2 rats received modified pellet diet along with carvacrol (80 mg/kg b.wt/day); Groups 3–6 received subcutaneous injection of DMH (20 mg/kg b.wt), once a week for the first 4 weeks; in addition Groups 4–6 received carvacrol at three different doses of 20, 40, and 80 mg/kg b.wt/day for 16 weeks. Results: Our result suggest that increased tumor incidence and increased number of ACF, increased bacterial enzymes accompanied by a decrease in the colonic lipid peroxidation, glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT) activities were observed in DMH-treated rats. Administration of carvacrol to DMH-treated rats significantly decreased the tumor incidence and the number of ACF and bacterial enzymes with enhancement of colonic lipid peroxidation, GPx, SOD, and CAT activities. Conclusion: The results of this study suggest that carvacrol at a dose of 40 mg/kg b.wt showed a significant beneficial effect against chemically-induced colon carcinogenesis in rats.

1 November 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Karthikkumar VenkatachalamKarthikkumar Venkatachalam
Karthikkumar Venkatachalam
SGSivagami Gunasekaran
Sivagami Gunasekaran
NNNalini Namatchivayam
Nalini Namatchivayam